首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1334276篇
  免费   101301篇
  国内免费   4267篇
耳鼻咽喉   16797篇
儿科学   43581篇
妇产科学   36371篇
基础医学   197844篇
口腔科学   35904篇
临床医学   129595篇
内科学   258095篇
皮肤病学   26373篇
神经病学   111856篇
特种医学   48177篇
外国民族医学   366篇
外科学   184076篇
综合类   28774篇
现状与发展   1篇
一般理论   460篇
预防医学   114405篇
眼科学   28981篇
药学   98833篇
  6篇
中国医学   3166篇
肿瘤学   76183篇
  2021年   10901篇
  2019年   11634篇
  2018年   16319篇
  2017年   12288篇
  2016年   13247篇
  2015年   15193篇
  2014年   20805篇
  2013年   32053篇
  2012年   44241篇
  2011年   46893篇
  2010年   27082篇
  2009年   24920篇
  2008年   42713篇
  2007年   45064篇
  2006年   45169篇
  2005年   43589篇
  2004年   41562篇
  2003年   39499篇
  2002年   38308篇
  2001年   60842篇
  2000年   62519篇
  1999年   52277篇
  1998年   14581篇
  1997年   13275篇
  1996年   13115篇
  1995年   12459篇
  1994年   11627篇
  1993年   10925篇
  1992年   41574篇
  1991年   40763篇
  1990年   39449篇
  1989年   37349篇
  1988年   34586篇
  1987年   33698篇
  1986年   32152篇
  1985年   30645篇
  1984年   23039篇
  1983年   19598篇
  1982年   11758篇
  1979年   20808篇
  1978年   14823篇
  1977年   12067篇
  1976年   11881篇
  1975年   12112篇
  1974年   14806篇
  1973年   14477篇
  1972年   13360篇
  1971年   12420篇
  1970年   11486篇
  1969年   10412篇
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
61.
62.
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (= 768 SMV/PR,= 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity.  相似文献   
63.
European Journal of Orthopaedic Surgery & Traumatology - The goals of this study were to compare patient satisfaction and wound-related complications in patients receiving 2-octyl cyanoacrylate...  相似文献   
64.
65.
66.
Annals of Nuclear Medicine - The Response Evaluation Criteria In Solid Tumors (RECIST) is the most used radiological method for evaluating response after peptide receptor radionuclide therapy...  相似文献   
67.
68.
69.
Porocarcinoma is an unusual, locally aggressive and potentially fatal neoplasm. Several cutaneous malignancies have been described in association with porocarcinoma, including squamous cell carcinoma, basal cell carcinoma and tricholemmal carcinoma. Previous reports have indicated that the occurrence of malignant tumours in combination with porocarcinoma is extremely rare, in particular with regard to Bowen disease (BD). We report an uncommon case of porocarcinoma occurring synchronously in a single BD lesion in a 63‐year‐old woman with multiple BD lesions. The clinical and histological findings confirmed this diagnosis.  相似文献   
70.
Reactive lymphoid infiltrates of the skin composed predominantly of gamma‐delta (γδ) T cells are not well described in the literature. Herein we report a case of an otherwise healthy 4‐year‐old male who presented with a waxing and waning papular rash characterized by small, discrete crusted papules spread across his trunk, face and extremities. Clinical evaluation revealed no evidence of systemic disease. Microscopic examination revealed a dermal, perivascular infiltrate of highly atypical lymphocytes with a γδ T cell phenotype, worrisome for primary cutaneous γδ T cell lymphoma. The clinical course, however, was that of a reactive condition and prompted consideration of a diagnosis of pityriasis lichenoides et varioliformis acuta (PLEVA) and lymphomatoid papulosis (LyP). In many ways, this case defies current classification schemes and seems to expand the spectrum of reactive γδ T cell infiltrates of the skin.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号